Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.TeaForHealth has introduced two new anticancer green tea products, based on the de facto standard recommended by the National Cancer Institute for effectiveness against cancer. The new product lines will be the first bottled loose-leaf green tea to meet the standard and will be available in four ready-to-drink flavors.
Subscribe to our email newsletter
Based on the National Cancer Institute (NCI) pharmacodynamics data published in 1996, daily consumption of 1,200ml of green tea containing 710mcg/ml epigallocatechin gallate (EGCG), which is used to measure green tea antioxidant levels, is equivalent to 1.5 times the lowest effective dose in an average person.
“Green tea inhibits cancer effectively, even in humans, if it is consumed according to the recommendations of the National Cancer Institute,” explained Dr Sin Hang Lee, founder of TeaForHealth and cancer pathologist who successfully petitioned the FDA to issue its first qualified health claim for green tea.
Dr Lee went on to say, “Up to 10 times the lowest effective dose can be well tolerated by cancer patients if properly administered. Whether used alongside chemotherapy or for cancer prevention, the issue has been that green tea of the NCI-defined strength is rarely available to the American consumers. We’re very excited to introduce the first loose-leaf and ready-to-drink green teas in a cancer-fighting strength to America.”